Livzon Pharmaceutical Group, Inc. (LVZPF)
3.799
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Livzon Pharmaceutical Group Shareholders Equity (Quarterly) : 1.970B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.970B |
| March 31, 2026 | 2.100B |
| December 31, 2025 | 1.987B |
| September 30, 2025 | 1.962B |
| June 30, 2025 | 1.909B |
| March 31, 2025 | 1.953B |
| December 31, 2024 | 1.899B |
| September 30, 2024 | 2.018B |
| June 30, 2024 | 1.916B |
| March 31, 2024 | 2.021B |
| December 31, 2023 | 1.980B |
| September 30, 2023 | 1.868B |
| June 30, 2023 | 1.847B |
| March 31, 2023 | 2.079B |
| December 31, 2022 | 1.996B |
| September 30, 2022 | 1.894B |
| June 30, 2022 | 1.922B |
| March 31, 2022 | 2.138B |
| December 31, 2021 | 2.040B |
| September 30, 2021 | 1.939B |
| June 30, 2021 | 1.857B |
| March 31, 2021 | 1.910B |
| December 31, 2020 | 1.851B |
| September 30, 2020 | 1.703B |
| June 30, 2020 | 1.569B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.637B |
| December 31, 2019 | 1.603B |
| September 30, 2019 | 1.521B |
| June 30, 2019 | 1.534B |
| March 31, 2019 | 1.641B |
| December 31, 2018 | 1.551B |
| September 30, 2018 | 1.555B |
| June 30, 2018 | 1.566B |
| March 31, 2018 | 1.761B |
| December 31, 2017 | 1.654B |
| September 30, 2017 | 1.593B |
| June 30, 2017 | 1.011B |
| March 31, 2017 | 984.65M |
| December 31, 2016 | 936.18M |
| September 30, 2016 | 944.96M |
| June 30, 2016 | 702.74M |
| March 31, 2016 | 708.30M |
| December 31, 2015 | 669.31M |
| September 30, 2015 | 658.21M |
| June 30, 2015 | 683.47M |
| March 31, 2015 | 662.97M |
| December 31, 2014 | 595.83M |
| September 30, 2014 | 588.04M |
| June 30, 2014 | 561.59M |
| March 31, 2014 | 560.80M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.477B |
| Total Liabilities (Quarterly) | 1.291B |
| Debt to Equity Ratio | 0.317 |
| Current Ratio | 1.550 |
| Net Debt Paydown Yield | 0.23% |